Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
October 28, 2025
Oct. 26, 2025 – Jupiter Endovascular, Inc., a medical technology company developing a new class of endovascular ...
October 27, 2025
Oct. 27, 2025 — The American Heart Association (Association) has launched its latest professional certification program ...
October 27, 2025
Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...
October 23, 2025
Oct. 22, 2025 — Basking Biosciences, a clinical-stage biopharmaceutical company developing the first reversible ...
October 22, 2025
Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...
October 21, 2025
Oct. 21, 2025 — At the seventeenth edition of the World Stroke Congress in Barcelona, Siemens Healthineers will present ...
October 21, 2025
Oct. 16, 2025 — Imbria Pharmaceuticals, has announced a partnership with the Hypertrophic Cardiomyopathy Association ...
October 16, 2025
Feature | Renal Denervation | Kyle Hardner
Hypertension remains the leading modifiable driver of cardiovascular disease and premature death.1 Even with multiple ...
October 02, 2025
Sept. 24, 2025 — The Family Heart Foundation, a leading research and advocacy organization, has announced the online ...
September 24, 2025
Sept. 23, 2025 — Ultromics, a pioneer in AI-driven cardiology solutions, has announced findings from its new study on ...
September 24, 2025
Sept. 23, 2025 — CeleCor Therapeutics’ multinational Phase 3 clinical trial of its investigational heart-attack drug ...
September 23, 2025
Sept. 22, 2025 — The latest findings on heart failure (HF) published by the Heart Failure Society of America (HFSA) reve ...
September 22, 2025
Sept. 18, 2025 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...
September 19, 2025
Sept. 17, 2025 — Imperative Care recently announced positive efficacy and safety results from the pivotal Symphony-PE ...
September 18, 2025